Homeobox Gene Six3 in Forebrain and Visual System Development
同源盒基因 Six3 在前脑和视觉系统发育中的作用
基本信息
- 批准号:8372363
- 负责人:
- 金额:$ 43.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-03-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AnteriorBindingBlindnessBrainCell TherapyCellsCerebellumComplexCoupledDegenerative DisorderDevelopmentDiseaseEctodermEligibility DeterminationEmbryoExcisionEye DevelopmentFishesFutureGenesGoalsHeadHomeoboxHomeobox GenesIn VitroInjection of therapeutic agentKnowledgeLens PlacodesMesodermMidbrain structureMolecularMolecular ProfilingMorphogenesisMovementMusMutationNeural RetinaOptic vesicleOrganismPathogenesisPrimordiumProcessProsencephalonProteinsRNAReplacement TherapyRetinaRetinalRetinal DegenerationRoleSensorySeriesSideSignal PathwaySignal TransductionSpecific qualifier valueStructure of retinal pigment epitheliumTherapeuticTissuesVisual FieldsVisual system structureWorkcell fate specificationcell typedesignembryonic stem celleye formationgastrulationin vivoinduced pluripotent stem cellmembermouse modelneural plateneurodevelopmentnoveloptic cupoptic stalkprogramsrelating to nervous systemresponseretinal progenitor cellspatiotemporaltranscription factorvision development
项目摘要
DESCRIPTION (provided by applicant): Congenital retina abnormalities such as retinal degenerative diseases cause varying degrees of irreversible vision loss in millions of people worldwide. Although recent advances in our understanding of retinal development have facilitated the use of screening protocols to detect mutations in genes associated with those ocular diseases, no therapeutic approach is yet available. A conserved network of transcription factors is essential for eye formation. The homeobox-containing gene Six3 is one of the members of that complex network that regulates visual system development. Conditional removal of Six3 from the developing mouse eye field is sufficient to arrest NR specification; a result demonstrating the critical role of Six3 during vertebrate retina development. The work proposed in this application builds on our previous findings and our generated mouse models to expand our knowledge about the processes leading to the formation of the visual system.
PUBLIC HEALTH RELEVANCE: Recent advances using embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) suggest that one day cell-replacement therapy will be used to treat these ocular diseases. A prerequisite to achieving this goal is to better understand the regulatory cascades and signaling pathways that control normal retina development. This knowledge will help us to better understand the pathogenesis of ocular diseases and provide the essential framework necessary to design approaches that will facilitate future efforts aimed toward controlling the differentiation of ESCs and iPSCs, in vivo and in vitro, into retina cells.
描述(由申请人提供):先天性视网膜异常,如视网膜退行性疾病,导致全世界数百万人不同程度的不可逆视力丧失。虽然我们对视网膜发育的理解的最新进展促进了使用筛查方案来检测与这些眼部疾病相关的基因突变,但还没有可用的治疗方法。一个保守的转录因子网络对于眼睛的形成是必不可少的。含有同源框的基因Six 3是调节视觉系统发育的复杂网络的成员之一。有条件地从发育中的小鼠视野中去除Six 3足以阻止NR特化;这一结果表明Six 3在脊椎动物视网膜发育过程中的关键作用。本申请中提出的工作建立在我们以前的发现和我们生成的小鼠模型的基础上,以扩展我们对导致视觉系统形成的过程的知识。
公共卫生相关性:使用胚胎干细胞(ESC)和诱导多能干细胞(iPSC)的最新进展表明,有一天细胞替代疗法将用于治疗这些眼部疾病。实现这一目标的先决条件是更好地理解控制正常视网膜发育的调节级联和信号通路。这些知识将帮助我们更好地了解眼部疾病的发病机制,并提供必要的框架来设计方法,这些方法将促进未来的努力,旨在控制ESC和iPSC在体内和体外分化为视网膜细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUILLERMO C OLIVER其他文献
GUILLERMO C OLIVER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUILLERMO C OLIVER', 18)}}的其他基金
11th Latin American Society for Developmental Biology (LASDB) Conference
第 11 届拉丁美洲发育生物学会 (LASDB) 会议
- 批准号:
10827693 - 财政年份:2023
- 资助金额:
$ 43.75万 - 项目类别:
Mitochondrial respiration as a regulator of lymphatic cell fate and therapeutic lymphangiogenesis
线粒体呼吸作为淋巴细胞命运和治疗性淋巴管生成的调节剂
- 批准号:
10640152 - 财政年份:2022
- 资助金额:
$ 43.75万 - 项目类别:
Functional roles of lymphatics in organogenesis and tissue repair
淋巴管在器官发生和组织修复中的功能作用
- 批准号:
10326857 - 财政年份:2021
- 资助金额:
$ 43.75万 - 项目类别:
Functional roles of lymphatics in organogenesis and tissue repair
淋巴管在器官发生和组织修复中的功能作用
- 批准号:
10117366 - 财政年份:2021
- 资助金额:
$ 43.75万 - 项目类别:
Functional roles of lymphatics in organogenesis and tissue repair
淋巴管在器官发生和组织修复中的功能作用
- 批准号:
10543140 - 财政年份:2021
- 资助金额:
$ 43.75万 - 项目类别:
2012 Gordon Conference on Molecular Mechanisms in Lymphatic Function and Disease
2012 年戈登淋巴功能与疾病分子机制会议
- 批准号:
8302116 - 财政年份:2012
- 资助金额:
$ 43.75万 - 项目类别:
THE ROLE OF THE HOMEOBOX SIX3 IN HOLOPROSENCEPHALY/CYCLOPIA
同源框 SIX3 在前脑无裂畸形/独眼畸形中的作用
- 批准号:
7387386 - 财政年份:2006
- 资助金额:
$ 43.75万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 43.75万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 43.75万 - 项目类别:
Continuing Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 43.75万 - 项目类别:
Standard Grant
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 43.75万 - 项目类别:
Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 43.75万 - 项目类别:
Fellowship
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 43.75万 - 项目类别:
Discovery Projects
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 43.75万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 43.75万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 43.75万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 43.75万 - 项目类别:
Discovery Projects